Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy: Determining the Balance Between Benefits and Risks.
Phase of Trial: Phase III
Latest Information Update: 03 Dec 2016
At a glance
- Drugs Dalteparin sodium (Primary) ; Nadroparin calcium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Acronyms Pot-Kast
- 03 Dec 2016 Results of two trials (POT-KAST and POT-CAST) published in the New England Journal of Medicine
- 10 Oct 2016 Status changed from active, no longer recruiting to completed.
- 31 May 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2016.